REGISTERED
on 05 Sep 2023
Last Applicant/ Owned by
3545 Cray Court
San Diego
CA
92121
Serial Number
97541713 filed on 09th Aug 2022
Registration Number
7159331 registered on 05th Sep 2023
Correspondent Address
Marilyn F. Kelly
Marilyn F. Kelly Bristol-Myers Squibb Company
Trademark Dept., Mailstop D.4243
Princeton, NJ 08648-4000
United States
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
KRAZATI
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceuti Read More
Classification Information
Class [005]
Pharmaceutical Products
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
First Use Date in General
13th Dec 2022
First Use Date in Commerce
13th Dec 2022
Mark Details
Serial Number
No 97541713
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 00163768-US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 25th Jun 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 25th Jun 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 25th Jun 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 05th Sep 2023 | REGISTERED-PRINCIPAL REGISTER |
| 05th Sep 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 02th Aug 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 01st Aug 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 10th May 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 08th May 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 19th Apr 2023 | USE AMENDMENT FILED |